公共技术平台

Public technology platform

  • Antibody drug R&D platform

    With core capability in new biomarker discovery and antibody development, the platform relies on its efficient CHO cell expression system to provide technical services including gene cloning, protein expression and purification, protein characterization, and druggability evaluation to help advanced R&D of the antibody drugs in the incubating companies.

Contact:Manager ShiTEL:0535-2607601